1. Home
  2. JF vs PPCB Comparison

JF vs PPCB Comparison

Compare JF & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JF

J and Friends Holdings Limited American Depositary Shares

SELL

Current Price

$0.90

Market Cap

17.4M

Sector

N/A

ML Signal

SELL

PPCB

Propanc Biopharma Inc.

SELL

Current Price

$1.78

Market Cap

18.1M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
JF
PPCB
Founded
2012
2007
Country
Hong Kong
Australia
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
18.1M
IPO Year
2017
2011

Fundamental Metrics

Financial Performance
Metric
JF
PPCB
Price
$0.90
$1.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.6K
★ 34.1K
Earning Date
12-01-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$0.06
52 Week High
$1.19
$6.79

Technical Indicators

Market Signals
Indicator
JF
PPCB
Relative Strength Index (RSI) 45.09 59.23
Support Level $0.81 $1.61
Resistance Level $1.03 $1.99
Average True Range (ATR) 0.04 0.15
MACD -0.00 -0.04
Stochastic Oscillator 0.13 43.63

Price Performance

Historical Comparison
JF
PPCB

About JF J and Friends Holdings Limited American Depositary Shares

J and Friends Holdings Ltd providing merchant digitalization and commerce-enablement solutions to small and medium enterprises (SME). Its solutions feature critical functionality that SMEs need to engage with consumers, manage their operations, accept payments, and grow their business. Such solutions empower single- and multi-location retailers, restaurants, and other SMEs to compete successfully in an omni-channel market environment by engaging with consumers across online, mobile, and physical channels. The group conducts all of its current operations in Australia and generates revenues from continuing operations are derived from within Australia.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: